Accustem Sciences Inc. (ACUT) stock
ACUTOTCPharmaceutical PreparationsFiscal year ends December 31
$0.15+0.00 (0.00%)
Close on Oct 16, 2026Market cap $2.37MP/E –Yield –
Accustem Sciences free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Accustem Sciences's free cash flow for the twelve months ending Dec 31, 2022 was -$1.82M. For fiscal 2022 it was -$1.82M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -$1.82M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | -$622.26K | – |
| Q3 FY2022 | Sep 30, 2022 | -$555.29K | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.00M | – |
| Q1 FY2022 | Mar 31, 2022 | $363.78K | – |
See a number that looks wrong?